Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-02

AUTHORS

John David M. Edgar, Alex G. Richter, Aarnoud P. Huissoon, Dinakantha S. Kumararatne, Helen E. Baxendale, Claire A. Bethune, Tomaz Garcez, Siraj A. Misbah, Ricardo U. Sorensen, United Kingdom Primary Immunodeficiency Network (UKPIN) Immunoglobulin Decision to Treat Study Group

ABSTRACT

BACKGROUND: Immunologists are increasingly being asked to assess patients with non-classical and secondary antibody deficiency to determine their potential need for immunoglobulin replacement therapy (IGRT). Immunoglobulin is a limited, expensive resource and no clear guidance exists for this broad patient group. The purpose of this survey is to establish what factors influence the decision to commence IGRT in adult patients, when diagnostic criteria for primary antibody deficiency are not fulfilled. METHODS: Under the auspices of the United Kingdom Primary Immunodeficiency Network (UKPIN), a study group was established which circulated an online questionnaire to the consultant body across the UK and Ireland. Results provided a snapshot of the current clinical practice of 71% of consultant immunologists, from 30 centers. RESULTS: In order of importance, factors which influence the decision to commence IGRT include number of hospital admissions with infection, serum IgG level, bronchiectasis, radiologically proven pneumonia, number of positive sputum cultures, number of antibiotic courses, and results of immunization studies. The commonest test vaccine used was Pneumovax 23 with measurement of serotype-specific responses at 4 weeks, with a threshold of 0.35 μg/ml in 2/3 of serotypes measured. Eighty-six percent of patients are treated with a trial of prophylactic antibiotics prior to consideration of IGRT. Efficacy of IGRT trial is assessed at between 6 and 12 months. CONCLUSIONS: There was consistency in clinical practice using a combination of clinical history, evidence of infections, and vaccination testing for diagnosis. However, there was some variation in the implementation of this practice, particularly in vaccine choice and assessment of response to vaccination. More... »

PAGES

204-213

References to SciGraph publications

  • 2014-02. Measurement of Pneumococcal Polysaccharide Antibodies in JOURNAL OF CLINICAL IMMUNOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s10875-017-0469-4

    DOI

    http://dx.doi.org/10.1007/s10875-017-0469-4

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1100921923

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/29423883


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Queen's University Belfast", 
              "id": "https://www.grid.ac/institutes/grid.4777.3", 
              "name": [
                "Regional Immunology Service, The Royal Hospitals, Belfast Health & Social Care Trust and Queen\u2019s University Belfast, Belfast, Northern Ireland, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Edgar", 
            "givenName": "John David M.", 
            "id": "sg:person.013631721142.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013631721142.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Queen Elizabeth Hospital Birmingham", 
              "id": "https://www.grid.ac/institutes/grid.415490.d", 
              "name": [
                "Clinical Immunology Service, Birmingham Medical School & University Hospitals, Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, B15 2GW, Birmingham, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Richter", 
            "givenName": "Alex G.", 
            "id": "sg:person.0603502337.80", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603502337.80"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Heartlands Hospital", 
              "id": "https://www.grid.ac/institutes/grid.413964.d", 
              "name": [
                "West Midlands Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Huissoon", 
            "givenName": "Aarnoud P.", 
            "id": "sg:person.01357413017.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357413017.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Department of Clinical Biochemistry and Immunology, Box 109, Addenbrooke\u2019s Hospital, CB2 0QQ, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kumararatne", 
            "givenName": "Dinakantha S.", 
            "id": "sg:person.01273317244.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273317244.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Papworth Hospital NHS Foundation Trust", 
              "id": "https://www.grid.ac/institutes/grid.412939.4", 
              "name": [
                "Papworth Hospital NHS Foundation Trust, Papworth Everard, CB23 3RE, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Baxendale", 
            "givenName": "Helen E.", 
            "id": "sg:person.01064477465.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064477465.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University Hospitals Plymouth NHS Trust", 
              "id": "https://www.grid.ac/institutes/grid.418670.c", 
              "name": [
                "Department of Clinical Immunology, Plymouth Hospitals NHS Trust, Plymouth, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bethune", 
            "givenName": "Claire A.", 
            "id": "sg:person.01352764335.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352764335.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Manchester University NHS Foundation Trust", 
              "id": "https://www.grid.ac/institutes/grid.498924.a", 
              "name": [
                "Manchester University NHS Foundation Trust, Manchester, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garcez", 
            "givenName": "Tomaz", 
            "id": "sg:person.01365017466.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365017466.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Oxford", 
              "id": "https://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Department of Clinical Immunology, Oxford University NHS Trust, OX3 9 DU, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Misbah", 
            "givenName": "Siraj A.", 
            "id": "sg:person.01166520514.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166520514.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Clinical Professor of Pediatrics, Department of Pediatrics, Louisiana State University Health Science Center, New Orleans, Louisiana, USA & Honorary Professor, Faculty of Medicine, University of La Frontera, Temuco, Chile"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sorensen", 
            "givenName": "Ricardo U.", 
            "id": "sg:person.01025423157.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025423157.77"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "United Kingdom Primary Immunodeficiency Network (UKPIN) Immunoglobulin Decision to Treat Study Group", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1111/cei.12172", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000532880"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jim.2004.11.006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008753731"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.iac.2015.07.003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009839798"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10875-013-9977-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014288789", 
              "https://doi.org/10.1007/s10875-013-9977-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/cei.12915", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014733541"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/aci.0000000000000215", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021454096"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/aci.0000000000000215", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021454096"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/aci.0000000000000215", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021454096"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1365-2249.2003.02232.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023542719"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3389/fimmu.2014.00627", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033414233"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jaci.2013.02.028", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036464360"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jaci.2016.09.023", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043058330"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.amjmed.2014.05.010", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044004476"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1128/cvi.00022-10", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051001913"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/hon.2323", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052947994"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1542/peds.2010-3680", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1067829141"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jaip.2016.11.033", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1074187699"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-02", 
        "datePublishedReg": "2018-02-01", 
        "description": "BACKGROUND: Immunologists are increasingly being asked to assess patients with non-classical and secondary antibody deficiency to determine their potential need for immunoglobulin replacement therapy (IGRT). Immunoglobulin is a limited, expensive resource and no clear guidance exists for this broad patient group. The purpose of this survey is to establish what factors influence the decision to commence IGRT in adult patients, when diagnostic criteria for primary antibody deficiency are not fulfilled.\nMETHODS: Under the auspices of the United Kingdom Primary Immunodeficiency Network (UKPIN), a study group was established which circulated an online questionnaire to the consultant body across the UK and Ireland. Results provided a snapshot of the current clinical practice of 71% of consultant immunologists, from 30 centers.\nRESULTS: In order of importance, factors which influence the decision to commence IGRT include number of hospital admissions with infection, serum IgG level, bronchiectasis, radiologically proven pneumonia, number of positive sputum cultures, number of antibiotic courses, and results of immunization studies. The commonest test vaccine used was Pneumovax 23 with measurement of serotype-specific responses at 4\u00a0weeks, with a threshold of 0.35\u00a0\u03bcg/ml in 2/3 of serotypes measured. Eighty-six percent of patients are treated with a trial of prophylactic antibiotics prior to consideration of IGRT. Efficacy of IGRT trial is assessed at between 6 and 12\u00a0months.\nCONCLUSIONS: There was consistency in clinical practice using a combination of clinical history, evidence of infections, and vaccination testing for diagnosis. However, there was some variation in the implementation of this practice, particularly in vaccine choice and assessment of response to vaccination.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s10875-017-0469-4", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1092207", 
            "issn": [
              "0271-9142", 
              "1573-2592"
            ], 
            "name": "Journal of Clinical Immunology", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "38"
          }
        ], 
        "name": "Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland", 
        "pagination": "204-213", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "d3487ab6c729b906afcf8e9fa1a856df3aac6e4b1d666f77fac159e3cd5ad733"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "29423883"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "8102137"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s10875-017-0469-4"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1100921923"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s10875-017-0469-4", 
          "https://app.dimensions.ai/details/publication/pub.1100921923"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T13:33", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000370_0000000370/records_46766_00000002.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1007%2Fs10875-017-0469-4"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10875-017-0469-4'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10875-017-0469-4'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10875-017-0469-4'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10875-017-0469-4'


     

    This table displays all metadata directly associated to this object as RDF triples.

    197 TRIPLES      21 PREDICATES      44 URIs      21 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s10875-017-0469-4 schema:about anzsrc-for:11
    2 anzsrc-for:1103
    3 schema:author Nafa2551466bf4229b9387ec2d96d4a5e
    4 schema:citation sg:pub.10.1007/s10875-013-9977-z
    5 https://doi.org/10.1002/hon.2323
    6 https://doi.org/10.1016/j.amjmed.2014.05.010
    7 https://doi.org/10.1016/j.iac.2015.07.003
    8 https://doi.org/10.1016/j.jaci.2013.02.028
    9 https://doi.org/10.1016/j.jaci.2016.09.023
    10 https://doi.org/10.1016/j.jaip.2016.11.033
    11 https://doi.org/10.1016/j.jim.2004.11.006
    12 https://doi.org/10.1046/j.1365-2249.2003.02232.x
    13 https://doi.org/10.1097/aci.0000000000000215
    14 https://doi.org/10.1111/cei.12172
    15 https://doi.org/10.1111/cei.12915
    16 https://doi.org/10.1128/cvi.00022-10
    17 https://doi.org/10.1542/peds.2010-3680
    18 https://doi.org/10.3389/fimmu.2014.00627
    19 schema:datePublished 2018-02
    20 schema:datePublishedReg 2018-02-01
    21 schema:description BACKGROUND: Immunologists are increasingly being asked to assess patients with non-classical and secondary antibody deficiency to determine their potential need for immunoglobulin replacement therapy (IGRT). Immunoglobulin is a limited, expensive resource and no clear guidance exists for this broad patient group. The purpose of this survey is to establish what factors influence the decision to commence IGRT in adult patients, when diagnostic criteria for primary antibody deficiency are not fulfilled. METHODS: Under the auspices of the United Kingdom Primary Immunodeficiency Network (UKPIN), a study group was established which circulated an online questionnaire to the consultant body across the UK and Ireland. Results provided a snapshot of the current clinical practice of 71% of consultant immunologists, from 30 centers. RESULTS: In order of importance, factors which influence the decision to commence IGRT include number of hospital admissions with infection, serum IgG level, bronchiectasis, radiologically proven pneumonia, number of positive sputum cultures, number of antibiotic courses, and results of immunization studies. The commonest test vaccine used was Pneumovax 23 with measurement of serotype-specific responses at 4 weeks, with a threshold of 0.35 μg/ml in 2/3 of serotypes measured. Eighty-six percent of patients are treated with a trial of prophylactic antibiotics prior to consideration of IGRT. Efficacy of IGRT trial is assessed at between 6 and 12 months. CONCLUSIONS: There was consistency in clinical practice using a combination of clinical history, evidence of infections, and vaccination testing for diagnosis. However, there was some variation in the implementation of this practice, particularly in vaccine choice and assessment of response to vaccination.
    22 schema:genre research_article
    23 schema:inLanguage en
    24 schema:isAccessibleForFree true
    25 schema:isPartOf N479b5bf1c4884e66867eaa7afa0e8b67
    26 N57fa78e70d0344d091f871dbefda0fff
    27 sg:journal.1092207
    28 schema:name Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland
    29 schema:pagination 204-213
    30 schema:productId N1a6fa5215f4e45199e19d9040d7e7b3b
    31 N4de830c30fbe4b65b22210c553028a6b
    32 N7ca532c164484442bbc1869ed933855c
    33 Nd806c8c115f94028881058b4bc641b25
    34 Nda65c51ff03646acb147255776b19d95
    35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100921923
    36 https://doi.org/10.1007/s10875-017-0469-4
    37 schema:sdDatePublished 2019-04-11T13:33
    38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    39 schema:sdPublisher N43403328b2684681875e005d36889bb6
    40 schema:url https://link.springer.com/10.1007%2Fs10875-017-0469-4
    41 sgo:license sg:explorer/license/
    42 sgo:sdDataset articles
    43 rdf:type schema:ScholarlyArticle
    44 N0e13f448b965433fa3cd8e7fb2efb1c7 rdf:first sg:person.01357413017.53
    45 rdf:rest N4674ae03b086497887c9c22b53859e92
    46 N1a6fa5215f4e45199e19d9040d7e7b3b schema:name pubmed_id
    47 schema:value 29423883
    48 rdf:type schema:PropertyValue
    49 N2e083dd5c61646988d34a4c9462c69d0 rdf:first sg:person.01365017466.16
    50 rdf:rest Naffb35019b0f4a51995c23205b14b420
    51 N43403328b2684681875e005d36889bb6 schema:name Springer Nature - SN SciGraph project
    52 rdf:type schema:Organization
    53 N4674ae03b086497887c9c22b53859e92 rdf:first sg:person.01273317244.08
    54 rdf:rest Nb7b290cfdd124adba5b8afdbbf6952bf
    55 N479b5bf1c4884e66867eaa7afa0e8b67 schema:volumeNumber 38
    56 rdf:type schema:PublicationVolume
    57 N4de830c30fbe4b65b22210c553028a6b schema:name dimensions_id
    58 schema:value pub.1100921923
    59 rdf:type schema:PropertyValue
    60 N4f7cf92eb9c043cd9f50d9e5e73bf313 rdf:first Nf7de6a2283c54aee9b3741b43d6ddbb1
    61 rdf:rest rdf:nil
    62 N57fa78e70d0344d091f871dbefda0fff schema:issueNumber 2
    63 rdf:type schema:PublicationIssue
    64 N78d476bf17b34065b8ce530445110707 schema:name Department of Clinical Biochemistry and Immunology, Box 109, Addenbrooke’s Hospital, CB2 0QQ, Cambridge, UK
    65 rdf:type schema:Organization
    66 N7ca532c164484442bbc1869ed933855c schema:name doi
    67 schema:value 10.1007/s10875-017-0469-4
    68 rdf:type schema:PropertyValue
    69 Naf9e197b63544fb09c61805265f56fd8 rdf:first sg:person.0603502337.80
    70 rdf:rest N0e13f448b965433fa3cd8e7fb2efb1c7
    71 Nafa2551466bf4229b9387ec2d96d4a5e rdf:first sg:person.013631721142.55
    72 rdf:rest Naf9e197b63544fb09c61805265f56fd8
    73 Naffb35019b0f4a51995c23205b14b420 rdf:first sg:person.01166520514.12
    74 rdf:rest Nf4d05f33295548fe9d6d1a685d99f909
    75 Nb7b290cfdd124adba5b8afdbbf6952bf rdf:first sg:person.01064477465.36
    76 rdf:rest Nb9e773ffe70a4ce09854cddce60ed3dc
    77 Nb9e773ffe70a4ce09854cddce60ed3dc rdf:first sg:person.01352764335.44
    78 rdf:rest N2e083dd5c61646988d34a4c9462c69d0
    79 Nc6109880575b4676aa4b0a2d0941b407 schema:name Clinical Professor of Pediatrics, Department of Pediatrics, Louisiana State University Health Science Center, New Orleans, Louisiana, USA & Honorary Professor, Faculty of Medicine, University of La Frontera, Temuco, Chile
    80 rdf:type schema:Organization
    81 Nd806c8c115f94028881058b4bc641b25 schema:name readcube_id
    82 schema:value d3487ab6c729b906afcf8e9fa1a856df3aac6e4b1d666f77fac159e3cd5ad733
    83 rdf:type schema:PropertyValue
    84 Nda65c51ff03646acb147255776b19d95 schema:name nlm_unique_id
    85 schema:value 8102137
    86 rdf:type schema:PropertyValue
    87 Nf4d05f33295548fe9d6d1a685d99f909 rdf:first sg:person.01025423157.77
    88 rdf:rest N4f7cf92eb9c043cd9f50d9e5e73bf313
    89 Nf7de6a2283c54aee9b3741b43d6ddbb1 schema:familyName United Kingdom Primary Immunodeficiency Network (UKPIN) Immunoglobulin Decision to Treat Study Group
    90 rdf:type schema:Person
    91 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    92 schema:name Medical and Health Sciences
    93 rdf:type schema:DefinedTerm
    94 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    95 schema:name Clinical Sciences
    96 rdf:type schema:DefinedTerm
    97 sg:journal.1092207 schema:issn 0271-9142
    98 1573-2592
    99 schema:name Journal of Clinical Immunology
    100 rdf:type schema:Periodical
    101 sg:person.01025423157.77 schema:affiliation Nc6109880575b4676aa4b0a2d0941b407
    102 schema:familyName Sorensen
    103 schema:givenName Ricardo U.
    104 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025423157.77
    105 rdf:type schema:Person
    106 sg:person.01064477465.36 schema:affiliation https://www.grid.ac/institutes/grid.412939.4
    107 schema:familyName Baxendale
    108 schema:givenName Helen E.
    109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064477465.36
    110 rdf:type schema:Person
    111 sg:person.01166520514.12 schema:affiliation https://www.grid.ac/institutes/grid.4991.5
    112 schema:familyName Misbah
    113 schema:givenName Siraj A.
    114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166520514.12
    115 rdf:type schema:Person
    116 sg:person.01273317244.08 schema:affiliation N78d476bf17b34065b8ce530445110707
    117 schema:familyName Kumararatne
    118 schema:givenName Dinakantha S.
    119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273317244.08
    120 rdf:type schema:Person
    121 sg:person.01352764335.44 schema:affiliation https://www.grid.ac/institutes/grid.418670.c
    122 schema:familyName Bethune
    123 schema:givenName Claire A.
    124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352764335.44
    125 rdf:type schema:Person
    126 sg:person.01357413017.53 schema:affiliation https://www.grid.ac/institutes/grid.413964.d
    127 schema:familyName Huissoon
    128 schema:givenName Aarnoud P.
    129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357413017.53
    130 rdf:type schema:Person
    131 sg:person.013631721142.55 schema:affiliation https://www.grid.ac/institutes/grid.4777.3
    132 schema:familyName Edgar
    133 schema:givenName John David M.
    134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013631721142.55
    135 rdf:type schema:Person
    136 sg:person.01365017466.16 schema:affiliation https://www.grid.ac/institutes/grid.498924.a
    137 schema:familyName Garcez
    138 schema:givenName Tomaz
    139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365017466.16
    140 rdf:type schema:Person
    141 sg:person.0603502337.80 schema:affiliation https://www.grid.ac/institutes/grid.415490.d
    142 schema:familyName Richter
    143 schema:givenName Alex G.
    144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603502337.80
    145 rdf:type schema:Person
    146 sg:pub.10.1007/s10875-013-9977-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1014288789
    147 https://doi.org/10.1007/s10875-013-9977-z
    148 rdf:type schema:CreativeWork
    149 https://doi.org/10.1002/hon.2323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052947994
    150 rdf:type schema:CreativeWork
    151 https://doi.org/10.1016/j.amjmed.2014.05.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044004476
    152 rdf:type schema:CreativeWork
    153 https://doi.org/10.1016/j.iac.2015.07.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009839798
    154 rdf:type schema:CreativeWork
    155 https://doi.org/10.1016/j.jaci.2013.02.028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036464360
    156 rdf:type schema:CreativeWork
    157 https://doi.org/10.1016/j.jaci.2016.09.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043058330
    158 rdf:type schema:CreativeWork
    159 https://doi.org/10.1016/j.jaip.2016.11.033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074187699
    160 rdf:type schema:CreativeWork
    161 https://doi.org/10.1016/j.jim.2004.11.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008753731
    162 rdf:type schema:CreativeWork
    163 https://doi.org/10.1046/j.1365-2249.2003.02232.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023542719
    164 rdf:type schema:CreativeWork
    165 https://doi.org/10.1097/aci.0000000000000215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021454096
    166 rdf:type schema:CreativeWork
    167 https://doi.org/10.1111/cei.12172 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000532880
    168 rdf:type schema:CreativeWork
    169 https://doi.org/10.1111/cei.12915 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014733541
    170 rdf:type schema:CreativeWork
    171 https://doi.org/10.1128/cvi.00022-10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051001913
    172 rdf:type schema:CreativeWork
    173 https://doi.org/10.1542/peds.2010-3680 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067829141
    174 rdf:type schema:CreativeWork
    175 https://doi.org/10.3389/fimmu.2014.00627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033414233
    176 rdf:type schema:CreativeWork
    177 https://www.grid.ac/institutes/grid.412939.4 schema:alternateName Papworth Hospital NHS Foundation Trust
    178 schema:name Papworth Hospital NHS Foundation Trust, Papworth Everard, CB23 3RE, Cambridge, UK
    179 rdf:type schema:Organization
    180 https://www.grid.ac/institutes/grid.413964.d schema:alternateName Heartlands Hospital
    181 schema:name West Midlands Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, UK
    182 rdf:type schema:Organization
    183 https://www.grid.ac/institutes/grid.415490.d schema:alternateName Queen Elizabeth Hospital Birmingham
    184 schema:name Clinical Immunology Service, Birmingham Medical School & University Hospitals, Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, B15 2GW, Birmingham, UK
    185 rdf:type schema:Organization
    186 https://www.grid.ac/institutes/grid.418670.c schema:alternateName University Hospitals Plymouth NHS Trust
    187 schema:name Department of Clinical Immunology, Plymouth Hospitals NHS Trust, Plymouth, UK
    188 rdf:type schema:Organization
    189 https://www.grid.ac/institutes/grid.4777.3 schema:alternateName Queen's University Belfast
    190 schema:name Regional Immunology Service, The Royal Hospitals, Belfast Health & Social Care Trust and Queen’s University Belfast, Belfast, Northern Ireland, UK
    191 rdf:type schema:Organization
    192 https://www.grid.ac/institutes/grid.498924.a schema:alternateName Manchester University NHS Foundation Trust
    193 schema:name Manchester University NHS Foundation Trust, Manchester, UK
    194 rdf:type schema:Organization
    195 https://www.grid.ac/institutes/grid.4991.5 schema:alternateName University of Oxford
    196 schema:name Department of Clinical Immunology, Oxford University NHS Trust, OX3 9 DU, Oxford, UK
    197 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...